Clear Harbor Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,075	Closed	-$277K	–	449
2024 Q4	$277K	Hold	3,075	–	–	0.02%	319
2024 Q3	$304K	Buy	3,075 +60	+2%	+$5.89K	0.02%	295
2024 Q2	$280K	Hold	3,015	–	–	0.02%	298
2024 Q1	$286K	Sell	3,015 -197	-6%	-$18.3K	0.03%	298
2023 Q4	$287K	Sell	3,212 -1,135	-26%	-$84.3K	0.03%	285
2023 Q3	$317K	Buy	4,347 +134	+3%	+$10.7K	0.03%	260
2023 Q2	$351K	Buy	4,213 +975	+30%	+$81.5K	0.03%	258
2023 Q1	$247K	Sell	3,238 -25	-0.8%	-$2.07K	0.03%	317
2022 Q4	$271K	Sell	3,263 -1,100	-25%	-$89.1K	0.03%	275
2022 Q3	$346K	Sell	4,363 -1,127	-21%	-$95K	0.05%	243
2022 Q2	$408K	Buy	+5,490	New	+$412K	0.05%	235
2022 Q1	–	Hold	0	–	–	–	456
2021 Q4	–	Hold	0	–	–	–	449
2020 Q4	–	Sell	-110	Closed	-$12.3K	–	738
2020 Q3	$12.3K	Buy	+110	New	+$12.3K	﹤0.01%	561